163 related articles for article (PubMed ID: 20047593)
41. Overexpression of myristoylated alanine-rich C-kinase substrate enhances activation of phospholipase D by protein kinase C in SK-N-MC human neuroblastoma cells.
Morash SC; Rosé SD; Byers DM; Ridgway ND; Cook HW
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):321-7. PubMed ID: 9601059
[TBL] [Abstract][Full Text] [Related]
42. Inhibitors of actin polymerization and calmodulin binding enhance protein kinase C-induced translocation of MARCKS in C6 glioma cells.
Douglas DN; Fink HS; Rosé SD; Ridgway ND; Cook HW; Byers DM
Biochim Biophys Acta; 1997 Apr; 1356(2):121-30. PubMed ID: 9150270
[TBL] [Abstract][Full Text] [Related]
43. Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.
Yang Y; Chen Y; Saha MN; Chen J; Evans K; Qiu L; Reece D; Chen GA; Chang H
Leukemia; 2015 Mar; 29(3):715-26. PubMed ID: 25179733
[TBL] [Abstract][Full Text] [Related]
44. Altered regulation of a major substrate of protein kinase C in rat 6 fibroblasts overproducing PKC beta I.
Guadagno SN; Borner C; Weinstein IB
J Biol Chem; 1992 Feb; 267(4):2697-707. PubMed ID: 1370830
[TBL] [Abstract][Full Text] [Related]
45. MARCKS actin-binding capacity mediates actin filament assembly during mitosis in human hepatic stellate cells.
Rombouts K; Mello T; Liotta F; Galli A; Caligiuri A; Annunziato F; Pinzani M
Am J Physiol Cell Physiol; 2012 Aug; 303(4):C357-67. PubMed ID: 22555845
[TBL] [Abstract][Full Text] [Related]
46. Specificity of the high affinity interaction of protein kinase C with a physiological substrate, myristoylated alanine-rich protein kinase C substrate.
Fujise A; Mizuno K; Ueda Y; Osada S; Hirai S; Takayanagi A; Shimizu N; Owada MK; Nakajima H; Ohno S
J Biol Chem; 1994 Dec; 269(50):31642-8. PubMed ID: 7989336
[TBL] [Abstract][Full Text] [Related]
47. Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils.
Sheats MK; Pescosolido KC; Hefner EM; Sung EJ; Adler KB; Jones SL
Vet Immunol Immunopathol; 2014 Aug; 160(3-4):167-76. PubMed ID: 24857637
[TBL] [Abstract][Full Text] [Related]
48. Sequestration of phosphoinositides by mutated MARCKS effector domain inhibits stimulated Ca(2+) mobilization and degranulation in mast cells.
Gadi D; Wagenknecht-Wiesner A; Holowka D; Baird B
Mol Biol Cell; 2011 Dec; 22(24):4908-17. PubMed ID: 22013076
[TBL] [Abstract][Full Text] [Related]
49. Protein kinase Cepsilon-dependent MARCKS phosphorylation in neonatal and adult rat ventricular myocytes.
Heidkamp MC; Iyengar R; Szotek EL; Cribbs LL; Samarel AM
J Mol Cell Cardiol; 2007 Feb; 42(2):422-31. PubMed ID: 17157309
[TBL] [Abstract][Full Text] [Related]
50. Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications.
Chen CH; Statt S; Chiu CL; Thai P; Arif M; Adler KB; Wu R
Am J Respir Crit Care Med; 2014 Nov; 190(10):1127-38. PubMed ID: 25318062
[TBL] [Abstract][Full Text] [Related]
51. Myristoylated alanine-rich C kinase substrate (MARCKS) is involved in myoblast fusion through its regulation by protein kinase Calpha and calpain proteolytic cleavage.
Dulong S; Goudenege S; Vuillier-Devillers K; Manenti S; Poussard S; Cottin P
Biochem J; 2004 Sep; 382(Pt 3):1015-23. PubMed ID: 15239673
[TBL] [Abstract][Full Text] [Related]
52. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity.
Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD
Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703
[TBL] [Abstract][Full Text] [Related]
53. New aspects of neurotransmitter release and exocytosis: Rho-kinase-dependent myristoylated alanine-rich C-kinase substrate phosphorylation and regulation of neurofilament structure in neuronal cells.
Sasaki Y
J Pharmacol Sci; 2003 Sep; 93(1):35-40. PubMed ID: 14501149
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of MARCKS and other calmodulin-binding protein kinase C substrates in cultured neuroblastoma and glioma cells.
Rosé SD; Cook HW; Palmer FB; Ridgway ND; Byers DM
J Neurochem; 1994 Dec; 63(6):2314-23. PubMed ID: 7964753
[TBL] [Abstract][Full Text] [Related]
55. Calmodulin and protein kinase C cross-talk: the MARCKS protein is an actin filament and plasma membrane cross-linking protein regulated by protein kinase C phosphorylation and by calmodulin.
Nairn AC; Aderem A
Ciba Found Symp; 1992; 164():145-54; discussion 154-61. PubMed ID: 1395931
[TBL] [Abstract][Full Text] [Related]
56. Phosphatidylinositol phosphate-dependent regulation of Xenopus ENaC by MARCKS protein.
Alli AA; Bao HF; Alli AA; Aldrugh Y; Song JZ; Ma HP; Yu L; Al-Khalili O; Eaton DC
Am J Physiol Renal Physiol; 2012 Sep; 303(6):F800-11. PubMed ID: 22791334
[TBL] [Abstract][Full Text] [Related]
57. Oxidant-induced activation of protein kinase C in UC11MG cells.
Brawn MK; Chiou WJ; Leach KL
Free Radic Res; 1995 Jan; 22(1):23-37. PubMed ID: 7889145
[TBL] [Abstract][Full Text] [Related]
58. Calpain and MARCKS protein regulation of airway mucin secretion.
Lampe WR; Park J; Fang S; Crews AL; Adler KB
Pulm Pharmacol Ther; 2012 Dec; 25(6):427-31. PubMed ID: 22710197
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor.
Ikenoya M; Hidaka H; Hosoya T; Suzuki M; Yamamoto N; Sasaki Y
J Neurochem; 2002 Apr; 81(1):9-16. PubMed ID: 12067241
[TBL] [Abstract][Full Text] [Related]
60. Protein kinase C-mediated phosphorylation and calmodulin binding of recombinant myristoylated alanine-rich C kinase substrate (MARCKS) and MARCKS-related protein.
Verghese GM; Johnson JD; Vasulka C; Haupt DM; Stumpo DJ; Blackshear PJ
J Biol Chem; 1994 Mar; 269(12):9361-7. PubMed ID: 8132675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
